Trastuzumab and paclitaxel in patients (pts) with EGFR mutated non-small-cell lung cancer (NSCLC) that express HER2 after progression on EGFR TKI treatment von De Langen, Joop, Kuiper, Justine Leonie, Thunnissen, Erik, Hashemi, Sayed MS, Monkhorst, Kim, Smit, Egbert F.

Volltext

Rebiopsy in TKI-resistance: A retrospective analysis von Kuiper, Justine Leonie, Heideman, Danielle, Thunnissen, Erik, Paul, M A, Smit, Egbert F.

Volltext

EML4-ALK rearrangement in blood platelets and outcome to crizotinib in non-small-cell lung cancer patients von Karachaliou, Niki, Nilsson, R. Jonas A., Berenguer, Jordi, Gimenez Capitan, Ana, Schellen, Pepijn, Teixido, Cristina, Kuiper, Justine Leonie, Drees, Esther, Grabowska, Magda, van Keulen, Marte, Tannous, Jihane M., Heideman, Danielle, Thunnissen, Erik, Dingemans, Anne-Marie C., Viteri Ramirez, Santiago, Tannous, Bakhos A., Drozdowskyj, Ana, Smit, Egbert F., Wurdinger, Thomas, Rosell, Rafael

Volltext